Mesoridazine and thioridazine: Clinical effects and blood levels in refractory schizophrenics

Journal of Clinical Psychiatry

Volumn 47, Issue 7, 1986, Pages 375-379

  Vital Herne, J ^a   Gerbino, L ^a   Kay, S R ^a   Katz, I R ^b   Opler, L A ^b  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHLORPROMAZINE; FLUPHENAZINE DECANOATE; HALOPERIDOL; LITHIUM CARBONATE; MESORIDAZINE; PERPHENAZINE; THIORIDAZINE; TIOTIXENE; TRIHEXYPHENIDYL;

CENTRAL NERVOUS SYSTEM; CLINICAL ARTICLE; DRUG BLOOD LEVEL; DRUG RESISTANCE; DRUG THERAPY; HUMAN; ORAL DRUG ADMINISTRATION; PHARMACOKINETICS; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; PSYCHOSIS; SCHIZOPHRENIA; THERAPY;

ADULT; ANTIPSYCHOTIC AGENTS; CHLORPROMAZINE; CLINICAL TRIALS; FEMALE; HOSPITALIZATION; HUMANS; KINETICS; MALE; MESORIDAZINE; PSYCHIATRIC STATUS RATING SCALES; RECEPTORS, DOPAMINE; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; THIORIDAZINE;

EID: 0022447458     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)